149 related articles for article (PubMed ID: 31826979)
1. Dementia is not synonymous with Alzheimer's disease.
Jack CR; Holtzman DM; Sperling R
Sci Transl Med; 2019 Dec; 11(522):. PubMed ID: 31826979
[No Abstract] [Full Text] [Related]
2. Tau PET: the next frontier in molecular imaging of dementia.
Xia C; Dickerson BC
Int Psychogeriatr; 2016 Sep; 28(9):1403-6. PubMed ID: 27334648
[TBL] [Abstract][Full Text] [Related]
3. Quantification of Tau Load in Alzheimer's Disease Clinical Trials Using Positron Emission Tomography.
Timmers T; van Berckel BNM; Lammertsma AA; Ossenkoppele R
Methods Mol Biol; 2018; 1750():221-229. PubMed ID: 29512076
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E genotype in senile dementia with tangles differs from Alzheimer's disease.
Tolnay M; Villoz N; Probst A; Miserez AR
Neuropathol Appl Neurobiol; 2003 Feb; 29(1):80-4. PubMed ID: 12581343
[No Abstract] [Full Text] [Related]
5. [Molecular imaging of Alzheimer's disease].
Albert A; Borbély K
Orv Hetil; 2019 Aug; 160(33):1289-1295. PubMed ID: 31401858
[TBL] [Abstract][Full Text] [Related]
6. Amyloid-induced neurofibrillary tangle formation in Alzheimer's disease: insight from transgenic mouse and tissue-culture models.
Götz J; Schild A; Hoerndli F; Pennanen L
Int J Dev Neurosci; 2004 Nov; 22(7):453-65. PubMed ID: 15465275
[TBL] [Abstract][Full Text] [Related]
7. Protein aggregation in Alzheimer's disease: Aβ and τ and their potential roles in the pathogenesis of AD.
Thal DR; Fändrich M
Acta Neuropathol; 2015 Feb; 129(2):163-5. PubMed ID: 25600324
[No Abstract] [Full Text] [Related]
8. [Tau protein abnormality and dementia: the mechanisms of neurodegeneration].
Tanaka T; Takeda M
No To Shinkei; 2002 Sep; 54(9):777-87. PubMed ID: 12428364
[No Abstract] [Full Text] [Related]
9. Direct determination of the proportion of intra- and extra-cellular neocortical neurofibrillary tangles in Alzheimer's disease.
Vickers JC; Tan A; Dickson TC
Brain Res; 2003 May; 971(1):135-7. PubMed ID: 12691846
[TBL] [Abstract][Full Text] [Related]
10. Non-invasive assessment of Alzheimer's disease neurofibrillary pathology using 18F-THK5105 PET.
Okamura N; Furumoto S; Fodero-Tavoletti MT; Mulligan RS; Harada R; Yates P; Pejoska S; Kudo Y; Masters CL; Yanai K; Rowe CC; Villemagne VL
Brain; 2014 Jun; 137(Pt 6):1762-71. PubMed ID: 24681664
[TBL] [Abstract][Full Text] [Related]
11. Untangling Alzheimer's disease from fibrous lesions of neurofibrillary tangles and senile plaques.
Mori H
Neuropathology; 2000 Sep; 20 Suppl():S55-60. PubMed ID: 11037189
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer's disease and amyloid: culprit or coincidence?
Skaper SD
Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834
[TBL] [Abstract][Full Text] [Related]
13. Pathological Changes of Tau Related to Alzheimer's Disease.
Chu D; Liu F
ACS Chem Neurosci; 2019 Feb; 10(2):931-944. PubMed ID: 30346708
[TBL] [Abstract][Full Text] [Related]
14. Power tools for Alzheimer's disease - an electrochemical preamp for Aβ.
Zetterberg H; Hammarström P
J Neurochem; 2012 Jul; 122(2):231-2. PubMed ID: 22409410
[No Abstract] [Full Text] [Related]
15. The molecular biology of senile plaques and neurofibrillary tangles in Alzheimer's disease.
Armstrong RA
Folia Neuropathol; 2009; 47(4):289-99. PubMed ID: 20054780
[TBL] [Abstract][Full Text] [Related]
16. Progression of neurofibrillary changes and PHF-tau in end-stage Alzheimer's disease is different from plaque and cortical microglial pathology.
Thal DR; Arendt T; Waldmann G; Holzer M; Zedlick D; Rüb U; Schober R
Neurobiol Aging; 1998; 19(6):517-25. PubMed ID: 10192210
[TBL] [Abstract][Full Text] [Related]
17. Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases.
Sasaki N; Fukatsu R; Tsuzuki K; Hayashi Y; Yoshida T; Fujii N; Koike T; Wakayama I; Yanagihara R; Garruto R; Amano N; Makita Z
Am J Pathol; 1998 Oct; 153(4):1149-55. PubMed ID: 9777946
[TBL] [Abstract][Full Text] [Related]
18. Discoveries of tau, abnormally hyperphosphorylated tau and others of neurofibrillary degeneration: a personal historical perspective.
Iqbal K; Grundke-Iqbal I
J Alzheimers Dis; 2006; 9(3 Suppl):219-42. PubMed ID: 16914861
[TBL] [Abstract][Full Text] [Related]
19. Fluid and PET biomarkers for amyloid pathology in Alzheimer's disease.
Cohen AD; Landau SM; Snitz BE; Klunk WE; Blennow K; Zetterberg H
Mol Cell Neurosci; 2019 Jun; 97():3-17. PubMed ID: 30537535
[TBL] [Abstract][Full Text] [Related]
20. Active caspase-6 and caspase-6-cleaved tau in neuropil threads, neuritic plaques, and neurofibrillary tangles of Alzheimer's disease.
Guo H; Albrecht S; Bourdeau M; Petzke T; Bergeron C; LeBlanc AC
Am J Pathol; 2004 Aug; 165(2):523-31. PubMed ID: 15277226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
